
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 4 chart positions in 4 markets.
By chart position
- 🇯🇵JP · Medicine#1721K to 10K
- 🇮🇳IN · Medicine#1941K to 10K
- 🇭🇺HU · Medicine#177500 to 3K
- 🇮🇱IL · Medicine#196500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1.5K to 13K🎙 ~2x weekly·138 episodes·Last published today - Monthly Reach
Unique listeners across all episodes (30 days)
3K to 26K🇯🇵38%🇮🇳38%🇭🇺12%+1 more - Active Followers
Loyal subscribers who consistently listen
1.2K to 10K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Episode 11.13 PMOS, PCOS, and the Metabolic Truth
Jun 25, 2026
1h 04m 06s
Episode 11.12 The Malpractice Crisis Is Real And Blaming Evidence-Based Care Makes It Worse
Jun 10, 2026
1h 01m 14s
Episode 11.11 When Evidence Misleads
May 28, 2026
1h 04m 23s
Episode 11.10 New Guidelines For Cervical Cancer Screening and More!
May 13, 2026
59m 58s
Episode 11.9 Vaccine Q&A
Apr 29, 2026
52m 51s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 6/25/26 | ![]() Episode 11.13 PMOS, PCOS, and the Metabolic Truth | Howard and guest hose Sivani Aluru unpack why the new PMOS name matters, how PCOS got tied to “cysts,” and what the evidence actually says about diagnosis, metabolic risk, and treatment. We also challenge a few habits we have all inherited, from pre-op antibiotic dosing to the way we talk about hormones, weight, and fertility with patients. • the evidence gap behind 2 g vs 3 g cefazolin in obese cesarean patients and how practice inertia forms • why PMOS shifts attention toward in... | 1h 04m 06s | ||||||
| 6/10/26 | ![]() Episode 11.12 The Malpractice Crisis Is Real And Blaming Evidence-Based Care Makes It Worse | We push back on the idea that obstetrics “deserves” a malpractice crisis and explain how bad incentives and junk science can turn normal evidence-based care into courtroom blame. We also break down a few widely shared clinical myths and new research so we can practice with clearer eyes and less narrative noise. • placental grading on ultrasound as low-value data with poor predictive power and high reader variability • how malpractice commentary can seed plaintiff-friendly arguments agai... | 1h 01m 14s | ||||||
| 5/28/26 | ![]() Episode 11.11 When Evidence Misleads | We sit down with Joshua Oommen to get nerdy about clinical reasoning, FDA standards, and why “good evidence” is harder to define than most of us admit. We challenge the reflex to trust p-values and meta-analyses, then test our instincts against real OBGYN examples where the literature has whiplashed practice. • why the podcast is called Thinking About OBGYN and how clinical reasoning shapes our work • the NEJM proposal to make one pivotal trial the FDA default and what “confirmato... | 1h 04m 23s | ||||||
| 5/13/26 | ![]() Episode 11.10 New Guidelines For Cervical Cancer Screening and More! | We bring back the biggest takeaways from the ACOG ACSM, then move fast through the newest guidance and the newest hype shaping real OBGYN care. We focus on what the evidence actually supports, where practice still lags behind, and how “labels” can quietly push patients toward harm. • conference highlights including rural OBGYN access and what gets attention on the exhibit floor • vitamin K shot refusal trends and why late bleeding still matters weeks after birth • 2026 ACOG cervi... | 59m 58s | ||||||
| 4/29/26 | ![]() Episode 11.9 Vaccine Q&A | We answer vaccine questions head-on, using real numbers to separate online fear from how vaccines, immunity, and public health actually work. We break down why diseases feel “gone,” what the modern schedule really exposes babies to, and how to spot misleading claims around ingredients, autism, and VAERS. Featuring Kate Moloney and our vaccine-hesitant friend Anah. • why vaccine success makes diseases look eradicated while risk returns when coverage drops • Stanford modeling estim... | 52m 51s | ||||||
| 4/15/26 | ![]() Episode 11.8 MTHFR, Bed Rest, and More! | We take on four stubborn myths in modern obstetrics and follow the evidence instead of the vibes, from thrombophilia testing to bed rest to seizure prophylaxis. We also spotlight a patient-empowering insulin strategy that may improve gestational diabetes outcomes faster than usual care. • distinguishing recurrent pregnancy loss evaluation from venous thromboembolism testing • focusing thrombophilia workups on antiphospholipid antibody syndrome when criteria are met • explain... | 1h 00m 44s | ||||||
| 4/2/26 | ![]() Episode 11.7 Professional Guideline Discrepancies on Labor And Delivery | We talk with Dr. Emily Donelan about how conflicting labor management guidelines can derail communication between nurses and physicians and quietly raise patient safety risks. We map the biggest friction points and lay out practical ways to reconcile guidance locally while pushing for a unified national approach. • defining “communication dystocia” and why guideline discrepancies create real bedside conflict • how evidence gaps drive teams toward institutional culture and inertia... | 1h 02m 32s | ||||||
| 3/19/26 | ![]() Episode 11.6 Ovarian Torsion & The Pitt | We use a plotline from The Pit to separate ovarian torsion facts from TV fiction and explain why Doppler findings can’t replace clinical judgment. Then we answer a listener question on trial of labor after myomectomy and how we counsel when the data are thin and the details matter. • why “competency porn” and “certainty porn” can distort real expectations of care • how color Doppler actually works and why red and blue do not always mean artery and vein • PCOS misconceptions... | 56m 50s | ||||||
| 3/5/26 | ![]() Episode 11.5 Gray Journal Cesarean Delivery Edition | We unpack the Gray Journal’s special edition on Cesarean Delivery, separating strong evidence from expert habit, and spotlight where technique, culture, and policy collide. From TXA and barbed sutures to better metrics and imaging, we share what to adopt now and what to question. Featuring Maddie White. • evidence versus expert opinion across the special issue • TXA at cesarean shows no meaningful outcome gains • barbed versus braided sutures and the cost of “speed” • why fundamentals beat g... | 59m 45s | ||||||
| 2/19/26 | ![]() Episode 11.4 Syphilis and lots more! | We examine why U.S. maternal mortality headlines mislead, showing overdose and violence dominate early postpartum deaths while obstetric causes decline. We then cover strong evidence for opportunistic salpingectomy, debunk a shaky Cochrane-fueled home birth claim, clarify Nexplanon’s five-year approval and bleeding management, confirm no Tylenol-autism link, and walk through modern syphilis testing in pregnancy before closing with pragmatic magnesium use after delivery. • overdose and violen... | 1h 09m 01s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 2/4/26 | ![]() Episode 11.3 Preventing Surgical Complications | We map a prevention-first approach to OBGYN surgical complications—from environmental fixes and technique to early detection, skilled repair, and honest recovery—so fewer patients are harmed and clinicians carry less hidden burden. Practical steps, board-level reasoning, and real cases bring it to life. • applying primordial to quaternary prevention to surgical harm • avoiding unnecessary hysterectomy and favoring safer routes • bladder repair tactics by size and location • ureter injury rec... | 1h 01m 45s | ||||||
| 1/22/26 | ![]() Episode 11.2 Rethinking VBAC Risk and a Lot More! | We unpack new studies that reshape how we counsel on VBAC after short intervals, update what we tell BRCA carriers about estrogen therapy, and explore how self-collected HPV tests can reduce screening gaps. We also question surgical marketing, workforce trends, and the shaky evidence behind aspirin dosing for preeclampsia. • Short interpregnancy interval as a VBAC risk factor, not a contraindication • Absolute uterine rupture rates in spontaneous vs induced labor • Estrogen therapy in BRCA c... | 1h 00m 00s | ||||||
| 1/8/26 | ![]() Episode 11.1 Smarter Hysterectomies, Lower Costs | Jamie Perry joins this episode as we share ten standout women’s health breakthroughs from 2025 and then get practical about value in endoscopic hysterectomy. The focus is simple: cut waste, save time, protect quality, and expand access through better selection, technique, and team flow. • Key 2025 breakthroughs shaping care and counseling • Why OR time outweighs device price • Preference cards as a lever to reduce waste • Three-arm robotics and smarter instrument choices • Laparoscopic tips:... | 55m 40s | ||||||
| 12/25/25 | ![]() Episode 10.13 Estrogen, Free Birth, And Misinformation | We unpack what WHI actually showed about estrogen-only therapy and breast cancer in light of new supporting data, then confront the free birth trend’s preventable harms and the business model behind it. We share clear tools to spot false claims, review new aspirin data on preeclampsia, and outline twelve practical ways to cut waste in gyn surgery. • estrogen-only therapy associated with lower breast cancer diagnosis and mortality • combined estrogen plus progestogen neutralizing estrogen’s p... | 1h 02m 47s | ||||||
| 12/11/25 | ![]() Episode 10.12 The V-Word | We trace the arc from variolation and Jenner to mRNA, show how vaccines leverage natural immunity, and explain why maternal shots protect both parent and newborn. Data, history, and personal stories make the case that prevention beats cure for OBGYN care. • pertussis surge in Kentucky and preventable infant deaths • child mortality then and now and what changed • variolation to Jenner and the origins of vaccination • how innate and adaptive immunity learn and remember • vaccine types and why... | 1h 00m 00s | ||||||
| 11/27/25 | ![]() Episode 10.11 Smarter Cancer Screening, Safer Obstetrics | We share a practical, clinic‑tested system for hereditary cancer screening that standardizes intake and education, then confront how malpractice pressures distort obstetric decision‑making, fetal monitoring, and access to care. Former ACOG president Dr. Richard Waldman offers data, history, and solutions we can use now. • digital workflow that screens every patient annually from age 18 • video education improving informed consent and test completion • one in four patients meeting... | 57m 13s | ||||||
| 11/13/25 | ![]() Episode 10.10 Habits That Help Doctors Thrive | Antonia and special guest Kristi Angevine explore how physicians can rethink habits beyond routines to include default thoughts, feelings, and reactions, and how that shift relieves burnout and restores purpose. Practical micro-habits, internal validation, and redefining productivity help us lead better and live better. • habits as automatic thoughts, feelings, reactions • perfectionism, people pleasing, catastrophizing as learned solutions • survival seasons and low‑friction wins • two micr... | 1h 00m 13s | ||||||
| 10/30/25 | ![]() Episode 10.9 Fibroids, Facts, False Beliefs, and More! | We challenge long-held beliefs about fibroids, highlight new ectopic pregnancy nuances, and dig into real-world dermoid cyst outcomes. We also unpack the evidence and ethics of 39-week induction after IVF and ICSI, balancing small absolute risks with maternal tradeoffs. • Evidence overturning links between fibroids and miscarriage, PROM and abruption • Distinguishing spontaneous versus iatrogenic preterm birth in fibroid pregnancies • Why myomectomy can raise early delivery and cesarean rate... | 1h 06m 36s | ||||||
| 10/16/25 | ![]() Episode 10.8 Speed in Surgery (+Circs & Autism) | In this episode, Howard and Maddie White challenge shaky claims linking autism to circumcision and Tylenol, then zero in on speed as the byproduct of essential, evidence-based surgery. We show how essentialism, confidence, and efficiency reduce complications, lower costs, and improve outcomes in the OR. • correlation vs causation in autism narratives and bias in research • why operative time predicts complications across procedures • surgeon volume, variability, and outcome differences • evi... | 55m 19s | ||||||
| 10/2/25 | ![]() Episode 10.7 Tylenol and Autism | We push back on claims that Tylenol or vaccines cause autism and explain how weak methods, conflicts of interest, and cherry-picked data fuel public panic. We also unpack why diagnoses have risen—broad criteria, screening, and access—not because of a new environmental villain. • Summary of claims made at the press event and why they fail • What the cited acetaminophen paper did and didn’t show • Conflicts of interest, pay-to-publish venues, and bias • Why correlation isn’t causation; confoun... | 1h 02m 06s | ||||||
| 9/17/25 | ![]() Episode 10.6 Natural Birth Claims | Dr. Howard Herrell explores common questions about birth alternatives posed by Anna, a mom-to-be with questions, examining scientific evidence behind claims often found online that challenge evidence-based obstetric practices. The discussion separates facts from philosophy by analyzing actual research data on interventions like epidurals, oxytocin, and birthing positions. • Maternal mortality has decreased 173-fold since 1850, coinciding with the rise of modern obstetrics • The "cascade of i... | 58m 56s | ||||||
| 9/4/25 | ![]() Episode 10.5 The Dense Breast Dilemma | Howard and Antonia explore the safety of medications during pregnancy and the controversial reporting requirements for breast density on mammograms, examining how science is being overshadowed by fear-mongering in healthcare decision-making. • Examining the evidence behind avoiding fluconazole (Diflucan) in first trimester, finding that short courses likely pose minimal risk • Discussing the important distinction between possibility and probability when evaluating medication safety in pregna... | 57m 40s | ||||||
| 8/21/25 | ![]() Episode 10.4 Noah | Dr. Jacqueline Vidosh shares her powerful journey as both an obstetrician and mother to Noah, who has trisomy 18, challenging traditional medical understanding of this condition and providing insights into compassionate patient care. Her story, recently featured in The New York Times, illustrates how medical perspectives on chromosomal conditions can evolve through lived experience, highlighting the spectrum nature of trisomy 18 and the importance of accurate, unbiased counseling. • Receivin... | 59m 32s | ||||||
| 8/7/25 | ![]() Episode 10.3 Post-Cesarean Antibiotics, Hysteroscopy, and More! | Recent evidence challenges the practice of prescribing oral antibiotics after Cesarean delivery in obese patients, finding no significant reduction in infection rates compared to standard preoperative antibiotics alone. Howard and Antonia analyze studies showing why this once-promising intervention may not be necessary. • ACOG updates delayed cord clamping guidance to minimum 60 seconds for preterm infants • Baby born at 21 weeks and zero days celebrates first birthday, highlighting advances... | 1h 11m 23s | ||||||
| 7/23/25 | ![]() Episode 10.2 Bridging Obstetrics and Neonatology: Saving Our Tiniest Patients | Dr. Scott Guthrie joins us to explore the significant advances in neonatal care and the critical partnership between obstetricians and neonatologists to improve outcomes for newborns. Highlights include: • Successful implemented delayed cord clamping across Tennessee hospitals through collaborative quality improvement project • Neonatal mortality has decreased 30% between 1999-2022 due to advances in medical care and prenatal management • Survival rates for 22-week premature infants ha... | 1h 13m 03s | ||||||
Showing 25 of 143
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
4 placements across 4 markets.
Chart Positions
4 placements across 4 markets.
